Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

341. There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea

There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all. Together. Take (...) There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea Ben Balevi B.Eng, D.D.S., Dip EBHC(Oxford), M.Sc. . Overview Systematic Review Conclusion The efficacy of a mandibular advancement device (MAD) depends on a number of factors, including the severity of obstructive sleep apnea (OSA), the materials and methods used to fabricate the device and the degree of mandibular protrusion. Critical Summary Assessment Evidence from randomized controlled trials

2014 ADA Center for Evidence-Based Dentistry

342. Bilevel positive airway pressure for the treatment of obstructive sleep apnea in adults

of obstructive sleep apnea in adults. Lansdale: HAYES, Inc.. Directory Publication. 2013 Authors' conclusions Bilevel positive airway pressure (BiPAP) for the treatment of obstructive sleep apnea (OSA) is a technological intervention that delivers airflow during sleep to reduce and/or prevent the occurrence of apneas (periods of no breathing). BiPAP is a form of positive airway pressure therapy that delivers airflow at different rates during the inspiration (inhalation) versus expiration (exhalation) phases (...) of breathing. This therapy has been suggested for use in patients who may have trouble exhaling against the continuous flow of air that is delivered by the more commonly prescribed continuous positive airway pressure (CPAP) treatment for OSA. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Adult; Humans; Positive-Pressure Respiration; Sleep Apnea, Obstructive Language Published English Country of organisation United States English summary

2014 Health Technology Assessment (HTA) Database.

343. Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1

Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1 Zostavax zur Pravention von herpes zoster und postherpetischer neuralgie. Deutsche kurzfassung zum gleichnamigen EUnetHTA Bericht [Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA (...) -1] Zostavax zur Pravention von herpes zoster und postherpetischer neuralgie. Deutsche kurzfassung zum gleichnamigen EUnetHTA Bericht [Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1] Zechmeister-Koss I Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment

2014 Health Technology Assessment (HTA) Database.

344. Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines

of literature identified, only citations published between 2011 and 2013 were included. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Cognitive Therapys; Sleep Initiation and Maintenance Disorders Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada (...) Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made

2014 Health Technology Assessment (HTA) Database.

345. Sleep medications for adults diagnosed with insomnia: clinical evidence and harms

Sleep medications for adults diagnosed with insomnia: clinical evidence and harms Sleep medications for adults diagnosed with insomnia: clinical evidence and harms Sleep medications for adults diagnosed with insomnia: clinical evidence and harms CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Sleep medications for adults (...) diagnosed with insomnia: clinical evidence and harms. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Reference List. 2013 Authors' conclusions Five systematic reviews and meta-analyses, 19 randomized controlled trials, and eight observational studies were identified regarding potential harms and dependence with the use of sleep medications for adults diagnosed with insomnia. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Adult

2014 Health Technology Assessment (HTA) Database.

346. Retesting patients with sleep apnea: guidelines and recommendations

: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2013 Authors' conclusions One health technology assessment was identified regarding the frequency at which adult or pediatric patients with sleep apnea should be retested after diagnosis. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Predictive Value of Tests; Respiratory Function Tests; Sleep Apnea, Obstructives Language Published English Country of organisation Canada (...) Retesting patients with sleep apnea: guidelines and recommendations Retesting patients with sleep apnea: guidelines and recommendations Retesting patients with sleep apnea: guidelines and recommendations CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Retesting patients with sleep apnea: guidelines and recommendations. Ottawa

2014 Health Technology Assessment (HTA) Database.

347. Upper-airway stimulation for obstructive sleep apnea. Full Text available with Trip Pro

surgically implanted an upper-airway stimulation device in patients with obstructive sleep apnea who had difficulty either accepting or adhering to CPAP therapy. The primary outcome measures were the apnea-hypopnea index (AHI; the number of apnea or hypopnea events per hour, with a score of ≥15 indicating moderate-to-severe apnea) and the oxygen desaturation index (ODI; the number of times per hour of sleep that the blood oxygen level drops by ≥4 percentage points from baseline). Secondary outcome (...) Upper-airway stimulation for obstructive sleep apnea. Obstructive sleep apnea is associated with considerable health risks. Although continuous positive airway pressure (CPAP) can mitigate these risks, effectiveness can be reduced by inadequate adherence to treatment. We evaluated the clinical safety and effectiveness of upper-airway stimulation at 12 months for the treatment of moderate-to-severe obstructive sleep apnea.Using a multicenter, prospective, single-group, cohort design, we

2014 NEJM Controlled trial quality: uncertain

348. Practice Guidelines for the Perioperative Management of Patients with Obstructive Sleep Apnea

, expert and practitioner opinion, open-forum commentary, and clinical feasibility data. This document updates the “Practice Guidelines for the Perioperative Management of Obstructive Sleep Apnea: a Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Obstructive Sleep Apnea,” adopted by the ASA in 2005 and published in 2006. Methodology A. Definition of Obstructive Sleep Apnea Obstructive sleep apnea (OSA) is a syndrome characterized by periodic, partial (...) Practice Guidelines for the Perioperative Management of Patients with Obstructive Sleep Apnea Practice Guidelines for the Perioperative Management of Patients with Obstructive Sleep Apnea:An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea | Anesthesiology | ASA Publications 1102063482 ASA Publications Log in to access full content You must be logged in to access this feature. ASA members enjoy

2014 American Society of Anesthesiologists

349. Hetlioz (tasimelteon) - To treat non-24- hour sleep-wake disorder (?non-24?) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep

Hetlioz (tasimelteon) - To treat non-24- hour sleep-wake disorder (?non-24?) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - HETLIOZ (tasimelteon) 20 mg oral Capsules Company: Vanda Pharmaceuticals, Inc. Application No.: 205677 Approval Date: 1/31/2014

2014 FDA - Drug Approval Package

350. Belsomra (suvorexant) - To treat difficulty in falling and staying asleep (insomnia)

Belsomra (suvorexant) - To treat difficulty in falling and staying asleep (insomnia) Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Belsomra (suvorexant, MK-4305) Oral Tablets Company: Merck & Co., Inc. Application No.: 204569 Approval Date: 8/13/2014 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF) (PDF) (PDF

2014 FDA - Drug Approval Package

351. Relaxation Training for Insomnia

., & Morin, C.M. (Eds.), Treatment of late-life insomnia (pp. 185-206). London: Sage Publications. Hauri, P., & Linde, S. (1996). Bedtime relaxation techniques. In Hauri, P., & Linde, S. (1996). No More Sleepless Nights (pp. 91-105). New York Press: John Wiley & Sons, Inc. Bernstein, D. A., & Borkovec, T. D. (1973). Progressive relaxation training . Champaign, IL: Research Press. Training Opportunities The Sleep Research Society Trainee Manual provides a variety of resources on training opportunities (...) gain mastery of the relaxation techniques. Although relaxation therapy is demonstrably effective, there is little evidence suggesting differential effectiveness across the range of relaxation modalities. Key References (in reverse chronological order) Morin, C., Bootzin, R., Buysse, D., Edinger, J., Espie, C., & Lichstein, K. (2006). Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep , 29, 1398-1414. Edinger, J.D., Wohlgemuth, W.K., Radtke, R.A

2014 Society of Clinical Psychology

352. Stimulus Control Therapy for Insomnia

). Nonpharmacologic treatment of chronic insomnia: An American Academy of Sleep Medicine review. Sleep , 22, 1134-1156. Riedel B., Lichstein, K.L., Peterson, B.A., Means, M.K., Epperson, M.T., & Aguillarel, R.N. (1998). A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs. Behavior Modification , 22, 3-28 Morin, C.M., & Azrin, N.H. Behavioral and cognitive treatments of geriatric insomnia (1988). Journal of Consulting and Clinical Psychology , 56, 748-753. Morin, C.M (...) Stimulus Control Therapy for Insomnia Stimulus Control Therapy for Insomnia – Society of Clinical Psychology Description The main goal in stimulus control therapy is to reduce the anxiety or conditioned arousal individuals may feel when attempting to go to bed. Specifically, a set of instructions designed to reassociate the bed/bedroom with sleep and to re-establish a consistent sleep schedule are implimented. These include: 1) Going to bed only when sleepy; 2) Getting out of bed when unable

2014 Society of Clinical Psychology

353. Sleep Restriction Therapy for Insomnia

Sleep Restriction Therapy for Insomnia Sleep Restriction Therapy for Insomnia – Society of Clinical Psychology Description Sleep restriction therapy utilizes a form of systematic sleep deprivation in which a sleep window is established and maintained to allow the body to (re)learn proper sleeping dynamics and increase sleep efficiency. For example, if a patient reports spending about 8 hours per night in bed, but only sleeps 6 of those hours, the amount of time in bed would be reduced (...) to closely match the amount of time the patient typically sleeps in bed (in this case, 6 hours). Periodic adjustments to this sleep window are made contingent upon sleep efficiency, until an optimal sleep duration is reached. Key References (in reverse chronological order) Morin, C., Bootzin, R., Buysse, D., Edinger, J., Espie, C., & Lichstein, K. (2006). Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep , 29, 1398-1414. Lichstein, K.L., Riedel, B.W

2014 Society of Clinical Psychology

354. Cognitive Behavioral Therapy for Insomnia

Summary Basic premise: The interaction between cognitive and behavioral factors is the key mechanism involved in the perpetuation of insomnia. Essence of therapy: Cognitive-behavioral therapy for insomnia focuses on teaching techniques to modify sleep disruptive behaviors and cognitions that interfere with normal sleep and contribute to insomnia. Length : approx. 6 sessions Treatment Resources Editors: John Otis, PhD Note: The resources provided below are intended to supplement not replace (...) foundational training in mental health treatment and evidence-based practice Treatment Manuals / Outlines Treatment Manuals Books Available for Purchase Through External Sites (Perlis, Aloia, & Kuhn) (Treatments That Work; Edinger & Carney) (Manber & Carney) Training Materials and Workshops Principles and Practice of Sleep Medicine (Kryger, Roth, & Dement; in press) (Morin & Espie) Etiology of Insomnia (Perlis et al.; in press) (Perlis et al.) (Szuba, Kloss, & Dinges) Measures, Handouts and Worksheets

2014 Society of Clinical Psychology

355. Biofeedback-Based Treatments for Insomnia

., & Lichstein, K. (2006). Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep , 29, 1398-1414. Barrowsky, E.I., Moskowitz, J., & Zweig, J.B. (1990). Biofeedback for disorders of initiating and maintaining sleep. Annals of the New York Academy of Sciences, 602 , 97-103. Sanavio, E., Vidotto, G., Bettinardi, O., Roletto, T., & Zorzi, M. (1990). Behavior therapy for DIMS: Comparison of three treatment procedures with follow-up. Behavioural Psychotherapy, 18 (...) , 151-167. VanderPlate, C., & Eno, E.N. (1983). Electromyograph biofeedback and sleep onset insomnia: Comparison of treatment and placebo. Behavioral Engineering, 8, 146-153 Nicassio, P.M., Boylan, M.B., & McCabe, T.G. (1982). Progressive relaxation, EMG biofeedback and biofeedback placebo in the treatment of sleep-onset insomnia. British Journal of Medical Psychology, 55,159-166. Freedman, R., & Papsdorf, J.D. (1976). Biofeedback and progressive relaxation treatment of sleep-onset insomnia

2014 Society of Clinical Psychology

356. Paradoxical Intention for Insomnia

Paradoxical Intention for Insomnia Paradoxical Intention for Insomnia – Society of Clinical Psychology Description Paradoxical intention is a cognitive technique that consists of persuading a patient to engage in his or her most feared behavior. In the context of insomnia, this type of therapy is premised on the idea that performance anxiety inhibits sleep onset. Paradoxically, if a patient stops trying to fall asleep and instead stays awake for as long as possible, the performance anxiety (...) is expected to diminish; thus, sleep may occur more easily. In clinical practice, some patients are fairly reluctant to use this procedure, and compliance is often problematic. Sleep restriction therapy, a similar technique with a different rationale, may be more readily accepted by patients. Key References (in reverse chronological order) Morin, C., Bootzin, R., Buysse, D., Edinger, J., Espie, C., & Lichstein, K. (2006). Psychological and behavioral treatment of insomnia: Update of the recent evidence

2014 Society of Clinical Psychology

357. Randomised controlled trial: Symptoms of obstructive sleep apnoea are treated by adenotonsillectomy, but without change in neurocognitive outcome

Text Therapeutics Randomised controlled trial Symptoms of obstructive sleep apnoea are treated by adenotonsillectomy, but without change in neurocognitive outcome James D Ramsden Statistics from Altmetric.com Commentary on: Marcus CL , Moore RH , Rosen CL , et al . A randomised trial of adenotonsillectomy for childhood sleep apnea . Context Adenotonsillectomy (T&A) in children is a very common surgical intervention for sleep disordered breathing and obstructive sleep apnoea (OSA). OSA in children (...) Randomised controlled trial: Symptoms of obstructive sleep apnoea are treated by adenotonsillectomy, but without change in neurocognitive outcome Symptoms of obstructive sleep apnoea are treated by adenotonsillectomy, but without change in neurocognitive outcome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see

2014 Evidence-Based Medicine

358. Hypoglossal nerve stimulation (Inspire Upper Airway Stimulation Inspire Medical Systems Inc.) for treatment of obstructive sleep apnea

hypoxemia, recurrent arousals from sleep, daytime sleepiness, apnea (cessation of breathing), hypopnea (shallow breathing), hypoxia (low blood oxygen concentration), hypercapnia (high blood carbon dioxide level), and loud snoring. Untreated OSA is more common in the aged and in obese and overweight patients and is associated with daytime sleepiness, fatigue, insomnia, decreased quality of life, and increased healthcare utilization. The apnea hypopnea index (AHI), which expresses the number of apnea (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation Hypoglossal nerve stimulation (Inspire Upper Airway Stimulation; Inspire Medical Systems Inc.) for treatment of obstructive sleep apnea. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2014 Authors' conclusions Obstructive sleep apnea (OSA) is a chronic disorder affecting 2% to 4% of adults. It is characterized by repetitive collapse of the oropharyngeal airway during sleep, with resultant nocturnal

2014 Health Technology Assessment (HTA) Database.

359. Stiripentol (Diacomit ? Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome)

Stiripentol (Diacomit ? Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome) Stiripentol (Diacomit — Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome) Stiripentol (Diacomit — Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome) CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation CADTH. Stiripentol (Diacomit — Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome) Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). CDEC Final Recommendation; SR0360. 2014 Authors' conclusions The Canadian Drug Expert Committee (CDEC) recommends that stiripentol be listed for use in combination with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic

2014 Health Technology Assessment (HTA) Database.

360. Systematic review: Individual clinical symptoms have limited utility in the diagnosis of obstructive sleep apnoea

Systematic review: Individual clinical symptoms have limited utility in the diagnosis of obstructive sleep apnoea Individual clinical symptoms have limited utility in the diagnosis of obstructive sleep apnoea | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Individual clinical symptoms have limited utility in the diagnosis of obstructive sleep apnoea Article Text Diagnosis Systematic review Individual clinical symptoms have limited

2014 Evidence-Based Medicine